[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hyperimmune Globulins Market Data Survey Report 2025

November 2018 | 78 pages | ID: G33D1731F36EN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The global Hyperimmune Globulins market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Major Application

Major Type

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
  • CSL Behring
  • Grifols 
  • Biotest
  • Kedrion
  • CBPO
  • Emergent (Cangene)
  • Emergent (Cangene)
  • CNBG
  • Hualan Bio
  • Shanghai RAAS
  • Sichuan Yuanda Shuyang
  • ADMA Biologics
Major applications as follows:
  • Government Institutions
  • Private Sector
  • Other

Major Type
as follows:
  • Hepatitis B Immunoglobulins
  • Rabies Immunoglobulins
  • Tetanus Immunoglobulins
  • Others
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 CSL Behring
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Grifols
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Biotest
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Kedrion
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 CBPO
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Emergent (Cangene)
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Emergent (Cangene)
  3.7.1 Company Information
  3.7.2 Product Specifications
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 CNBG
  3.8.1 Company Information
  3.8.2 Product Specifications
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Hualan Bio
  3.9.1 Company Information
  3.9.2 Product Specifications
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Shanghai RAAS
  3.10.1 Company Information
  3.10.2 Product Specifications
  3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Sichuan Yuanda Shuyang
3.12 ADMA Biologics

4 MAJOR APPLICATION

4.1 Government Institutions
  4.1.1 Overview
  4.1.2 Government Institutions Market Size and Forecast
4.2 Private Sector
  4.2.1 Overview
  4.2.2 Private Sector Market Size and Forecast
4.3 Other
  4.3.1 Overview
  4.3.2 Other Market Size and Forecast

5 MARKET BY TYPE

5.1 Hepatitis B Immunoglobulins
  5.1.1 Overview
  5.1.2 Hepatitis B Immunoglobulins Market Size and Forecast
5.2 Rabies Immunoglobulins
  5.2.1 Overview
  5.2.2 Rabies Immunoglobulins Market Size and Forecast
5.3 Tetanus Immunoglobulins
  5.3.1 Overview
  5.3.2 Tetanus Immunoglobulins Market Size and Forecast
5.4 Others
  5.4.1 Overview
  5.4.2 Others Market Size and Forecast

6 CONCLUSION

LIST OF TABLES

Tab REGIONAL PRODUCTION 2011-2017 (MILLION USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of CSL Behring
Tab Sales Revenue, Volume, Price, Cost and Margin of Grifols
Tab Sales Revenue, Volume, Price, Cost and Margin of Biotest
Tab Sales Revenue, Volume, Price, Cost and Margin of Kedrion
Tab Sales Revenue, Volume, Price, Cost and Margin of CBPO
Tab Sales Revenue, Volume, Price, Cost and Margin of Emergent (Cangene)
Tab Sales Revenue, Volume, Price, Cost and Margin of Emergent (Cangene)
Tab Sales Revenue, Volume, Price, Cost and Margin of CNBG
Tab Sales Revenue, Volume, Price, Cost and Margin of Hualan Bio
Tab Sales Revenue, Volume, Price, Cost and Margin of Shanghai RAAS
Tab Sales Revenue, Volume, Price, Cost and Margin of Sichuan Yuanda Shuyang
Tab Sales Revenue, Volume, Price, Cost and Margin of ADMA Biologics

LIST OF FIGURES

Fig Global Hyperimmune Globulins Market Size and CAGR 2011-2017 (Million USD)
Fig Global Hyperimmune Globulins Market Size and CAGR 2011-2017 (Volume)
Fig Global Hyperimmune Globulins Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Hyperimmune Globulins Market Forecast and CAGR 2018-2025 (Volume)
Fig Government Institutions Market Size and CAGR 2011-2017 (Million USD)
Fig Government Institutions Market Size and CAGR 2011-2017 (Volume)
Fig Government Institutions Market Forecast and CAGR 2018-2025 (Million USD)
Fig Government Institutions Market Forecast and CAGR 2018-2025 (Volume)
Fig Private Sector Market Size and CAGR 2011-2017 (Million USD)
Fig Private Sector Market Size and CAGR 2011-2017 (Volume)
Fig Private Sector Market Forecast and CAGR 2018-2025 (Million USD)
Fig Private Sector Market Forecast and CAGR 2018-2025 (Volume)
Fig Other Market Size and CAGR 2011-2017 (Million USD)
Fig Other Market Size and CAGR 2011-2017 (Volume)
Fig Other Market Forecast and CAGR 2018-2025 (Million USD)
Fig Other Market Forecast and CAGR 2018-2025 (Volume)
Fig Hepatitis B Immunoglobulins Market Size and CAGR 2011-2017 (Million USD)
Fig Hepatitis B Immunoglobulins Market Size and CAGR 2011-2017 (Volume)
Fig Hepatitis B Immunoglobulins Market Forecast and CAGR 2018-2025 (Million USD)
Fig Hepatitis B Immunoglobulins Market Forecast and CAGR 2018-2025 (Volume)
Fig Rabies Immunoglobulins Market Size and CAGR 2011-2017 (Million USD)
Fig Rabies Immunoglobulins Market Size and CAGR 2011-2017 (Volume)
Fig Rabies Immunoglobulins Market Forecast and CAGR 2018-2025 (Million USD)
Fig Rabies Immunoglobulins Market Forecast and CAGR 2018-2025 (Volume)
Fig Tetanus Immunoglobulins Market Size and CAGR 2011-2017 (Million USD)
Fig Tetanus Immunoglobulins Market Size and CAGR 2011-2017 (Volume)
Fig Tetanus Immunoglobulins Market Forecast and CAGR 2018-2025 (Million USD)
Fig Tetanus Immunoglobulins Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)


More Publications